These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology].
    Author: Burgos-Vargas R, Abud-Mendoza C, Díaz-Jouanen E, Garza-Elizondo MA, Medrano-Ramírez G, Orozco-Alcalá J, Pacheco-Tena C, Pineda-Villaseñor C, Carlos-Pozos J, Ramos-Niembro F, Robles-San Román M, Santana-Sahagún E.
    Journal: Gac Med Mex; 2009; 145(1):41-9. PubMed ID: 19256410.
    Abstract:
    We describe the guidelines for the current treatment of ankylosing spondylitis with an emphasis on the role and outlook of the Mexican rheumatologic community. The topics we analyze include: epidemiological as well as professional, financial, health status, and quality of life aspects. We propose to acknowledge that axial spondyloarthritis is the earliest form of ankylosing spondylitis. Finally we carry out a review of the literature supporting current therapeutic recommendations. Regarding the latter, we approached the ASAS/EULAR recommendations for the treatment of ankylosing spondylitis and their level of agreement with Mexican and other countries' rheumatologists. Finally, we analyzed the recommendations to start tumor necrosis alpha blockers among patients with ankylosing spondylitis.
    [Abstract] [Full Text] [Related] [New Search]